How QIAGEN's (QGEN) Diagnostics Expansion Strengthens Its Takeover Appeal [Yahoo! Finance]
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Yahoo! Finance
14, 2026, when QIAGEN said it was expanding into bloodstream infection syndromic testing with a new rapid QIAstat-Dx panel. The launch pushes the company into another clinically important diagnostics category and broadens the QIAstat-Dx menu beyond respiratory, gastrointestinal, and meningitis and encephalitis testing, reinforcing the strategic value of its diagnostics platform. That helps explain why takeover interest resurfaced earlier this year. On January 20, 2026, Reuters reported that QIAGEN was weighing strategic options, including a potential sale, amid fresh takeover interest and had engaged advisers as its supervisory board considered preliminary interest from potential buyers, including several U.S. strategic firms. The market took the report seriously. Reuters said QIAGEN's U.S.-listed shares rose more than 16% in afternoon trading on the news, giving the stock a clear takeover-driven momentum jolt. How QIAGEN's (QGEN) Diagnostics Expansion Strengthens Its Takeover App
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026Business Wire
- Qiagen (QGEN) was downgraded by Barclays PLC from "strong-buy" to "hold". They now have a $44.00 price target on the stock.MarketBeat
- QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx PanelBusiness Wire
- Qiagen (QGEN) was given a new $44.00 price target by Barclays PLC.MarketBeat
- Qiagen (QGEN) Upgraded to Buy by Deutsche Bank After 30% Decline [Yahoo! Finance]Yahoo! Finance
QGEN
Earnings
- 2/4/26 - Beat
QGEN
Sec Filings
- 3/20/26 - Form 20-F
- 3/20/26 - Form IRANNOTICE
- 2/10/26 - Form SCHEDULE
- QGEN's page on the SEC website